CARDLYTICS, INC. CDLX Cash Flow

Cardlytics, inc. (CDLX)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17
Finance Lease, Right-of-Use Asset, Amortization
0	-	-	-	0	-	-	-	-	-	-	-	-
Cash paid for interest
0	-	-	-	0	-	-	-	-	-	-	0	0
Operating activities
Net loss
-24,361	-17,144	-32,137	-32,758	-39,301	-53,042	-45,532	-39,638	-27,233	-19,641	0	0	0
Bad debt expense
0	-	-	-	0	-	-	-	-	-	-	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
5,905	4,535	3,992	3,602	3,333	3,282	3,196	3,190	3,173	3,028	0	0	0
Amortization of financing costs charged to interest expense
97	100	117	121	187	300	0	0	0	-	-	-	-
Accretion of debt discount and non-cash interest expense
-	-	-	-	-	2,326	3,781	8,934	8,241	6,889	0	0	0
Accretion of debt discount and non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	0	0
Termination of U.K. agreement expense
18,268	15,851	22,088	20,325	25,598	26,790	18,408	14,167	7,064	5,147	0	0	0
Fair Value Adjustment of Warrants
-	-	-	-	-	6,760	6,929	6,349	9,426	581	0	0	0
Fair Value Adjustment Of Convertible Promissory Notes
-	-	-	-	-	-	-	-	-	-1,244	0	0	0
Fair Value Adjustment Of Convertible Promissory Notes, Related Parties
-	-	-	-	-	-	-	-	-	6,213	0	0	0
Other non-cash (income) expense, net
-3,039	-631	-3,069	-1,917	-2,477	-4,771	0	0	0	-	-	-	-
Amortization of deferred FI implementation costs
3,224	2,869	2,655	2,244	1,859	1,618	0	0	0	-	-	-	-
Other non-cash expenses
-	-	-	-	-	-	-	-	-	-	-	-	0
Change in operating assets and liabilities:
Accounts receivable
8,609	26,018	26,098	24,151	13,309	9,426	-124	5,902	5,552	7,503	0	0	0
Prepaid expenses and other assets
1,560	2,224	1,846	2,388	1,928	2,275	1,371	1,805	1,635	666	0	0	0
Deferred FI implementation costs
-	-	-	-	-	-9,250	-10,000	-10,150	-12,112	-10,900	0	0	0
Contract with Customer, Asset, Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share, Net
3,468	4,625	4,813	5,000	5,193	5,380	0	0	0	-	-	-	-
Accounts payable
342	-601	289	1,444	628	911	-695	-2,563	-2,946	-1,907	0	0	0
Other accrued expenses
934	6,152	4,684	3,815	3,321	3,255	823	1,750	1,432	466	0	0	0
FI Share liability
7,680	14,301	13,511	9,859	1,993	3,742	2,229	-1,573	2,909	804	0	0	0
Customer Incentive liability
-994	8,385	11,043	9,652	8,268	4,234	-518	237	2,083	1,385	0	0	0
Total adjustment
-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash used in operating activities
9,534	11,457	2,662	-9,179	-20,388	-18,995	-19,831	-28,770	-16,368	-22,102	0	0	0
Investing activities
Payments to Acquire Property, Plant, and Equipment
7,277	8,277	7,291	8,447	6,994	5,920	3,434	2,219	1,247	1,215	0	0	0
Acquisition of patents
54	31	23	16	21	23	22	49	46	60	0	0	0
Capitalized software development costs
3,145	2,712	2,254	1,881	1,514	1,399	1,277	1,029	746	372	0	0	0
Net cash used in investing activities
-10,476	-11,020	-9,568	-10,344	-8,529	-7,342	-4,733	-3,297	-2,039	-1,647	0	0	0
Financing activities
Proceeds from issuance of debt
-	-	-	-	-	-	-	-	-	12,500	0	0	0
Repayments of Long-term Debt
46,699	46,698	46,798	10,780	52,560	52,581	52,500	51,861	101	99	0	0	0
Proceeds from issuance of common stock
94,188	91,216	82,077	3,020	2,017	72,334	71,812	70,193	70,450	230	0	0	0
Payments of Stock Issuance Costs
-	-	-	-	-	1,949	2,427	3,571	3,719	2,668	0	0	0
Debt issuance costs
137	143	143	93	54	48	0	0	0	-	-	-	-
Net cash from financing activities
47,156	44,179	35,098	-7,905	-3,879	65,191	64,272	62,148	83,428	21,761	0	0	0
Effect of exchange rates on cash, cash equivalents and restricted cash
-607	101	-574	-291	-301	-246	-82	52	411	282	0	0	0
Net decrease in cash, cash equivalents and restricted cash
45,607	44,717	27,618	-27,719	-33,097	38,608	39,626	30,133	65,432	-1,706	0	0	0
Supplemental schedule of non-cash investing and financing activities:
Stock-based compensation capitalized for software development
-	-	-	-	-	-	-	-	-	-	-	0	0